Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China flag China · Delayed Price · Currency is CNY
11.07
+0.03 (0.27%)
Feb 4, 2026, 3:04 PM CST

SHE:300485 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Net Income
81.2-68.85102.92204.73402.27154.9
Depreciation & Amortization
47.1847.1848.7447.655.6836.96
Other Amortization
0.070.07-0.031.041.44
Loss (Gain) From Sale of Assets
---0-6.65-6.57-0.17
Asset Writedown & Restructuring Costs
0.050.05-0.04-1.069.03
Loss (Gain) From Sale of Investments
108.13108.13-160.07-212.12-318.44-40.99
Provision & Write-off of Bad Debts
-1.17-1.17-1.59-0.61--
Other Operating Activities
-230.6-5.52-6.57-1.73-7.14-3.44
Change in Accounts Receivable
14.7114.7139.171.1734.4829.63
Change in Inventory
22.3622.36-17.9733.9636.5210.59
Change in Accounts Payable
37.9837.98-7.32-8.71-38.4263.89
Change in Other Net Operating Assets
0.390.39-3.45-3.86
Operating Cash Flow
60.95135.9721.21110.43183.3263.73
Operating Cash Flow Growth
-32.77%541.05%-80.79%-39.75%-30.50%52.86%
Capital Expenditures
-90.4-101.13-52.91-43.28-45.91-117.84
Sale of Property, Plant & Equipment
0.18-0.0310.9115.250.21
Cash Acquisitions
----4.43--
Investment in Securities
-84.43-99.45-48.9929.27-674.77-238.9
Other Investing Activities
69.6525.2215.6139.9242.969.15
Investing Cash Flow
-105-175.36-86.2632.39-662.47-347.39
Net Debt Issued (Repaid)
19.99-----
Issuance of Common Stock
4.74.7----
Common Dividends Paid
--10.59-41.4-80.88-31.31-30.02
Other Financing Activities
---0.72--1.62
Financing Cash Flow
24.69-5.89-41.4-80.16-31.31-31.64
Foreign Exchange Rate Adjustments
0.330.370.42-0.51-1.29
Net Cash Flow
-19.03-44.9-106.0564.67-510.99-116.59
Free Cash Flow
-29.4534.85-31.767.15137.38145.88
Free Cash Flow Growth
----51.12%-5.83%138.75%
Free Cash Flow Margin
-7.32%8.37%-6.65%9.14%13.07%13.33%
Free Cash Flow Per Share
-0.060.07-0.070.140.290.30
Cash Income Tax Paid
51.0421.7123.5749.2286.6798.35
Levered Free Cash Flow
-24.0130.21-33.1544.6392.4298.25
Unlevered Free Cash Flow
-24.0130.21-33.1544.6392.4298.36
Change in Working Capital
56.0956.0937.7979.1457.5106
Source: S&P Global Market Intelligence. Standard template. Financial Sources.